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Background 
Apathy is one of the most common neuropsychiatric symptoms in Parkinson’s disease (PD). Few 
studies have investigated the cognitive and neuroanatomical correlates of apathy in PD, and those 
which have done so have not controlled for the presence of other neuropsychiatric comorbidities.  
Objective 
To explore the cognitive and neuroanatomical correlates of apathy in PD at a mild disease stage. 
Methods 
Sixty-five PD patients and 24 healthy controls participated in this study. Patients underwent extensive 
neuropsychological screening, neuropsychiatric assessment using the Neuropsychiatric Inventory, 
structural MRI scanning, and neurological examination. A voxel-based multiple regression analysis 
was used to assess the relationship between grey matter volumes and apathy scores.   
Results 
Higher apathy scores correlated with lower grey matter volume in several brain areas including the 
left insula, left inferior/middle/medial frontal gyrus, right anterior cingulate, and the left superior 
temporal gyrus. Significant impairments were found in tests assessing executive functions, and a 
trend-level significant difference was observed in long term memory tests in patients with apathy, 
when compared with patients without apathy.  
Conclusions 
Apathy was associated with greater levels of atrophy in the frontal and temporal cortex, and anterior 
cingulate, as well as overall lower level of cognitive performance, particularly in executive function 
and memory skills. Apathy appears to be associated with cognitive impairments in PD, therefore, 
treatment of this symptom might mitigate its effects on cognitive performance in this clinical 
population.   
  
3 
 
1. INTRODUCTION 
 
Parkinson’s disease (PD) is a neurodegenerative disorder characterised by both motor symptoms 
(resting tremor, rigidity and bradykinesia) and non motor symptoms such as cognitive and 
neuropsychiatric symptoms [1].  One of the most frequent neuropsychiatric symptoms in PD is apathy 
[2-4].  Apathy refers to a combination of behavioural, emotional and cognitive features that leads to a 
reduced interest, and participation in daily life activities, together with lack of initiative, and lack of 
concern or indifference [5].  The prevalence of apathy in PD varies from 17- 70%, depending on the 
assessment procedures and the characteristics of the population [2, 5-8].  A recently published 
systematic review, and meta-analysis found that apathy affects about 40% of patients with PD [9] 
Several studies have indicated that apathy is correlated with cognitive impairments in patients 
with PD [4, 7, 10-18].  For instance, a study investigated cognitive abilities in a patient group (23 with 
apathy and 25 without apathy) using the Apathy Evaluation Scale (AES) [19] and digit span [20], the 
Delis-Kaplan Executive Function Test [21], the California Verbal Learning Test [22]  and the 
Wisconsin Card Sorting Test (WCST) [23].  There was a significant difference between patients with 
and without apathy on immediate free recall, short delay free recall, long delay free recall, long 
delayed cued recall, delayed recognition, digit span backward, and WCST (total correct, non-
perseverative errors and categories completed) [24].  A further study reported that in patients with PD 
with left-side onset, apathy scores significantly correlated with scores on non-verbal tasks e.g. Trail 
Making Test (part B), Wechsler Memory Test and Visual Symbol Search Test [25].  Another recent 
study indicated that apathetic patients with PD with akinetic-rigid type performed significantly worse 
on tasks assessing functions associated with the frontal lobe e.g. the Frontal Assessment Battery 
(FAB) [26], phonemic fluency [27] and the interference error score on the Stroop test [28] when 
compared with patients with PD with tremor-dominant type [15].    
Only a limited number of neuroimaging studies have investigated apathy in PD [29].  Apathy 
has been associated with deficits of the prefrontal-basal ganglia system [30]. A VBM study found that 
apathy was not correlated with the severity of motor symptoms, disease duration or proportion of 
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patients taking levodopa or a dopamine agonist.  In addition, high apathy scores were negatively 
correlated with less grey matter density in the left precentral gyrus, the bilateral inferior parietal gyrus, 
the bilateral inferior frontal gyrus, the bilateral insula and the right posterior cingulate gyrus [17].  
Another PET study reported positive correlations between AES scores and cerebral metabolism in the 
right inferior frontal gyrus, right middle frontal gyrus, right cuneus and right insula.  Negative 
correlations were identified between AES scores, and cerebral metabolism in the bilateral cerebellum 
particularly the inferior semilunar lobule [31].  A recent PET study reported that, after deep brain 
stimulation of the subthalamic nucleus, apathy was associated with reduced preoperative metabolism 
within the right ventral striatum [32].  
From the above literature, it appears that executive dysfunction and memory impairment are 
the most frequent cognitive difficulties in patients with PD with apathy, with imaging studies 
reporting associations between the presence of apathy in PD, and volumetric loss in frontal lobe and 
cingulate cortex. None of the previous studies investigated patients with apathy at a mild stage of PD, 
however, and previous findings might have not necessarily depicted the apathetic phenotype in PD, 
but rather a more severe disease level.   In addition, these studies included a limited number of 
participants, and some only used screening instruments that assessed general cognitive abilities, but 
did not evaluate in detail a broader range of cognitive functions.  Furthermore, there is no study which 
has assessed the possible presence of other neuropsychiatric comorbidities, and no study has 
investigated white matter volume in patients with PD with apathy.  In fact, in other neurological 
disorders, for instance AD,  a structural MRI study has found that patients with AD with apathy 
showed a significantly greater amount of frontal white matter hyperintensities than patients without 
apathy [8].  In addition, the cingulate area was also identified, when comparing patients with AD with 
apathy with patients with AD without apathy [33]. 
 
Therefore, taking into account the limitations of previous work, the present study was 
designed to explore both the cognitive and neuroanatomical correlates of apathy in a large sample of 
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patients with mild PD, exploring associations between the presence of this symptom, and volumetric 
changes in both grey and white matter.  This study assessed the cognitive profile of non-demented PD 
patients at early stages of disease using an extensive battery of neuropsychological tests that explored 
multiple cognitive domains.  
 
2. METHOD 
2.1. SAMPLE 
Sixty-five patients with idiopathic PD (31 male and 34 female) participated in this study.  The 
patients were recruited among those who had had extensive assessment in a PD specialised clinic.  
The patients were diagnosed based on the UK PD Brain Bank Criteria [34].  All patients had 
extensive neuropsychological screening, neuropsychiatric assessment using the NPI, structural MRI 
scanning and neurological examination.  All patients were in the mild disease stage, according to the 
Hoehn and Yahr (1967) staging [35] (specifically, patients were between stages 1 and 3).  None of the 
patients had a history of psychiatric disorders and the neuropsychiatric symptoms started after the 
onset of PD.  A larger cohort of 88 PD patients was originally recruited, but for 23 patients the MRI 
scans were of poor quality because of excessive movement artifacts and therefore not suitable for 
segmentation. The imaging study also included twenty-four healthy controls (6 males and 18 females) 
for comparison. None in the control group had a history of neurological or psychiatric diseases. For 
further detail, see table 1. 
- Insert Table 1 about here 
 
2.2. ASSESSMENTS OF APATHY  
Apathy was defined and assessed according to both the NPI [36], and DSM-IV- TR  [37].  
Each patient and their caregiver had had an interview with an experienced psychologist who also 
completed the NPI.  The NPI assesses the presence or absence, severity and frequency of 14 symptom 
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fields (patients who scored 1 or more were classified as having apathy).  Apathy scores from the NPI 
were then entered in the statistical analyses. The NPI was chosen because it allows the exclusion of 
other neuropsychiatric symptoms, avoiding, therefore, possible contamination of findings through the 
presence of comorbidities, a major limitation of earlier studies. The use of a single symptom based 
assessment such as for example The Lille Apathy Rating Scale [38] or The Apathy Evaluation Scale 
[19], although providing a more in depth characterisation of the symptom, would not have allowed the 
selection of a sample free from potential other neuropsychiatric comorbidities.   
 
2.3. NEUROPSYCHOLOGICAL ASSESSMENTS 
An extensive battery of cognitive tests was administered to each participant in order to assess various 
cognitive domains.  A trained neuropsychologist administered the assessments.  The cognitive 
domains included global cognitive abilities assessed by the MMSE [39], executive ability measured 
by the FAB [26, 40-42], Letter Fluency Test [41], Trail Making Test (TMT) [43], Stroop Test [28, 41, 
42, 44] and Digit Span (Backward) [45], abstract reasoning ability assessed by the Raven’s 
Progressive Matrices, version 1938 (PM38) (Black and white) [44] and Similarities Test [45], non-
verbal memory examined by the Rey Complex Figure Test (Delay) [41, 42, 46] and the Corsi Block-
tapping Test (Visual-spatial span) [41, 42, 47], verbal memory assessed by the Category Fluency Test 
(Verbal retrieval of semantic materials) [41], the Digit Span (Forward) [45] and the Rey 15-word 
Memory Test (Delay) [48] and visual-construction abilities measured by the Rey Complex Figure 
Test (Copy) [41, 42, 46]. 
  
2.4. STATISTICAL ANALYSES 
Univariate analyses of variance were carried out to compare demographical data and global cognitive 
screening as assessed by the MMSE of the three groups (patients with apathy, patients without any 
neuropsychiatric symptoms and healthy controls).  This study also used an independent T-test and a 
series of independent T-tests to compare the neuropsychological test scores of the two subgroups 
(patients with apathy and without neuropsychiatric symptoms).  Further statistical analyses were also 
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carried out to examine the relationship between apathy scores and neuropsychological test scores 
using the Pearson correlation test.  To account for multiple comparisons, this study used a significance 
level of 0.004 for both overall comparisons among groups and for paired correlations Post hoc 
(Bonferroni) comparisons were also used in order to determine possible significant differences 
between the patient subgroups (with and without apathy) and healthy control group in the 
demographical data and the MMSE and in this case significance level was 0.01. 
 
2.5. STRUCTURAL MRI SCANNING: ACQUISITION AND ANALYSIS 
Three dimensional T1- weighted MRI images were acquired on a 1.5 T Philips Achieva 
Scanner.  Voxel dimensions were 1.04 x 1.04 x 0.6 mm. Field of view was 230 mm with a matrix size 
of 240 x 240 x 280.  A number of pre-processing steps were followed to isolate the grey and white 
matter from the 3D T1-weighted structural scans before performing the statistical analysis using 
SPM8 imaging analysis software (Wellcome Centre for Neuroimaging, London, UK). 
To correct for global differences in brain shape, structural images were warped to standard 
stereotactic space and segmented to extract grey matter, white matter, and cerebrospinal fluid using 
the default segmentation procedure available in SPM8.  The grey and white matter segments were 
then modulated to correct for changes in volume induced by non-linear normalization and smoothed 
using a Gaussian filter set at 8 mm to reduce possible error from between subject variability in local 
anatomy and render the data more normally distributed.  These smoothed grey and white matter 
segments were entered into a voxel-based independent T test analysis for group comparisons to 
investigate the differences in grey and white matter volumes between the sample groups (PD with 
apathy versus PD without any neuropsychiatric symptoms, PD patients with apathy versus healthy 
control, PD without any neuropsychiatric symptoms versus healthy control).  Age, number of years of 
education, gender, and Total Intracranial Volume were also included in the model as covariates.  The 
x, y, z coordinates of significant areas obtained from the analyses were first converted into Talairach 
coordinates using the mni2tal Matlab routine and then identified using the Talairach Daemon Client 
(http://www.talairach.org/).  Unless otherwise stated, a cluster corrected height threshold of p < 0.001 
was used in all analyses.  An extent threshold was also applied to the different analyses.  A T2–
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weighted axial scan and a coronal Fluid Attenuated Inversion Recovery (FLAIR) scan were acquired 
after the 3-dimensional scan acquisition to better highlight any vascular load and ensure that all 
participants included in the 3-dimensional structural imaging study had no significant vascular 
burden.   
3. RESULTS 
3.1 DEMOGRAPHICAL AND MENTAL STATE SCREENING DATA ANALYSES 
Univariate analyses of variance were carried out to compare the three groups (PD with 
apathy, PD without neuropsychiatric symptoms and controls) in age, education, disease duration and 
MMSE.  The control and patient subgroups showed no significant difference in age [F (2, 63) = 2.31, 
P > .01] or education [F (2, 63) = .39, P > .01], but there was a significant difference in MMSE [F (2, 
63) = 25.965, p = .000].  Post hoc (Bonferroni) comparisons showed that there was no significant 
difference between the patient subgroup with apathy and those without neuropsychiatric symptoms in 
MMSE, but there was a significant difference between controls and each of the two subgroups of 
patients.  Also, patients with apathy and patients without neuropsychiatric symptoms did not differ for 
duration of disease [F (1, 39) = 2.1, P > .01] (Table 1).    
- Insert Table 1 about here – 
 
3.2 COGNITIVE PROFILE OF PATIENTS WITH PD WITH AND WITHOUT APATHY 
A series of independent T-tests was also carried out to compare the performance of patients 
with PD with and without neuropsychiatric symptoms on the neuropsychological tests in the battery. 
The subgroup with apathy had lower scores than the subgroup without apathy on the Stroop Test 
(error) t(63) = -3.16, p < .004 and the Letter Fluency Test t(63) = 3.17, p < .004. There were no 
significant differences between the two subgroups in any of the other neuropsychological tests, i.e. 
Raven’s Progressive Matrices t(63) = 2.91, p > .004, Stroop Test (time) t(63) = 0.43, p > .004, TMT 
t(63) = 1.54, p > .004, Category Fluency Test t(63) = 2.64, p > .004, Similarities Test t(63) = 1.26, p > 
.004 Rey Complex Figure (copy) t(63) = 2.92, p > .004, Rey Complex Figure (delayed) t(63) = 1.75, 
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p > .004, Digit Span (forward) t(63) = 0.80, p > .004, Digit Span (backward) t(63) = 1.01, p > .004, 
Frontal Assessment Battery t(63) = 2.63, p > .004, Visual-spatial span t(63) = 1.02, p > .004 and Rey 
15-word Memory Test t(63) = 2.47, p > .004 (see Table 2). 
 
- Insert Table 2 about here - 
 
Additional correlation analyses were carried out with apathy scores as the dependant variable 
and neuropsychological test scores as the independent variable in turn. There was a significant 
relationship between apathy scores and Letter Fluency scores (r= -.38, P = 0.002). Higher apathy 
scores were associated with lower performance on the Letter Fluency Test. Apathy scores were not 
significantly correlated with scores on Raven’s Progressive Matrices (r= -.22, P = .08), TMT (r= -.13, 
P = .29), Category Fluency (r= -.32, P = 0.009), Similarities Test (r= -.12, P = .34), Rey Complex 
Figure (copy) (r= -.26, P = 0.04), Rey Complex Figure (delayed) (r= -.23, P = .08), Stroop Test (time) 
(r= .036, P = .79), Stroop Test (error) (r= .27, P = .03), Frontal Assessment Battery (r= -.34, P = .04), 
Digit Span (forward) (r= -.23, P = .15), Digit Span (backward) (r= -.199, P = .22), Visual-spatial span 
(r= -.18, P = .26), Rey 15-word Memory Test (r= -.304, P = .04) and MMSE (r=-.28, P = .02). 
 
3.3 VOXEL-BASED MORPHOMETRY GROUP COMPARISONS OF GREY MATTER 
Patients with PD with apathy versus patients with PD without neuropsychiatric symptoms: At 
the corrected cluster level (p < 0.01), significant grey matter volume differences between the 
subgroups were detected in several brain areas including the left inferior frontal gyrus, left middle 
frontal gyrus, left precentral gyrus, left cingulate gyrus, right anterior cingulate, left superior temporal 
gyrus and the left insula in which patients with apathy had significantly less grey matter volume when 
compared with patients without apathy (Table 3 Figure 1). 
 
10 
- Insert Table 3 and Figure 1 about here - 
 
 
Patients with PD with apathy versus controls: At the corrected cluster level, patients with 
apathy had significantly less grey matter volume in the bilateral inferior frontal gyrus, bilateral middle 
frontal gyrus, right inferior parietal lobule, left parahippocampal gyrus, left cerebellum (anterior lobe, 
culmen), left cerebellum (posterior lobe, tuber), left fusiform gyrus and the left cingulate gyrus when 
compared with healthy controls (Table 3 Figure 1). 
 
Patients with PD without neuropsychiatric symptoms versus controls: At the corrected cluster 
level, patients without neuropsychiatric symptoms had less grey matter volume in the left inferior 
frontal gyrus and the left middle frontal gyrus when compared with healthy controls (Table 3 Figure 
1). 
                                                                           
3.4 VOXEL-BASED MORPHOMETRY GROUP COMPARISONS OF WHITE MATTER 
Patients with PD with apathy versus patients with PD without neuropsychiatric symptoms: 
There was no significant difference between patients with apathy and patients without 
neuropsychiatric symptoms in white matter volume values. 
 
Patients with PD with apathy versus controls: At the corrected cluster level, patients with 
apathy had less white matter volume in the bilateral middle frontal gyrus, right insula, bilateral 
anterior cingulate gyrus, and left precentral gyrus when compared with healthy controls (Table 4 
Figure 2). 
 
- Insert Table 4 and Figure 2 about here - 
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Patients with PD without neuropsychiatric symptoms versus controls: At the corrected cluster 
level, patients without neuropsychiatric symptoms had significantly less white matter volume values 
in the right medial frontal gyrus, left precentral gyrus and left middle frontal gyrus when compared 
with healthy controls (Table 4 and Figure 2). 
 
 
4. DISCUSSION   
This study is the first to have explored both the behavioural and the neuroanatomical correlates of 
apathy in the same cohort of patients with mild PD.  The behavioural results showed that although 
patients with apathy performed lower than those without neuropsychiatric symptoms on all 
neuropsychological tests, significant differences were detected in those tasks assessing executive 
functions.  Correlation analyses confirmed that high apathy scores correlated significantly with poorer 
performance on tests of executive function.  Executive dysfunction might reflect the difficulty in 
response inhibition, in thinking flexibly, and switching response sets in the present sample, suggesting 
that executive function tasks should be made a priority when evaluating patients with apathy at the 
mild stages of PD. 
The impairment of executive functions in patients with PD with apathy detected with the 
Stroop test has been found in previous studies [10, 12, 15].  Functional imaging studies have indicated 
the important role of the anterior cingulate cortex, which is activated during the Stroop test [49]. The 
evidence from this activation study might provide an explanation for the differences between the two 
subgroups on the Stroop task in the current study.  Additionally, the current study found a significant 
association between apathy and letter fluency scores, which is also in line with previous findings in 
more severe patients [4, 13, 15].  Moreover, a similar pattern of executive dysfunction has been 
reported in apathetic patients with PD with dementia and apathetic patients with AD [50].  Taken 
together, the findings of the present study highlight the presence of a strong association between 
apathy and the presence of executive deficits.  Impairments of executive functions most likely reflect 
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frontal lobe dysfunction. Although previous anatomical studies have reported an association between 
apathy and deficits in structures or in the functioning of the frontal lobe [17, 51, 52], the link between 
cognitive and neuroimaging features has always been speculative. There is, therefore, no previous 
study, which has investigated the cognitive and neuroimaging features associated with apathy in the 
same sample of patients with PD.  
 Apathy in PD, mainly in more advanced severity stages, has been the object of investigation 
of other studies.  These, however, have failed to control for other concomitant neuropsychiatric 
symptoms which, potentially, could have contaminated their results.  In this study the NPI was used as 
a tool to explore the neuropsychiatric profile of patients with PD since it would help the exclusion of 
other concurrent symptoms when exploring apathy.  The underlying mechanism of apathy is still 
unclear.  Although there are some published studies which have investigated the neural correlates of 
apathy using different approaches, little is known about the structural brain areas that may associate 
with this symptom.  For this purpose a VBM approach was chosen given that it offers a suitable way 
to explore grey and white matter volume changes as it has been championed for its powerful approach 
for unbiased hypothesis testing across the whole brain [53].          
 The present study identified some brain regions that may play an important role in the 
presence of apathy in mild PD.  In patients with apathy, a large cluster of grey and white matter loss 
was found in frontal lobe areas, anterior cingulate cortex and the insula.  These findings are partly in 
line with a previous study that found grey matter reduction in the frontal lobe regions, insula and the 
cingulate gyrus [17].  Consistent with the present findings, parallel earlier studies in AD patients with 
apathy also reported a white matter reduction in the frontal lobe [8] and in the anterior cingulate 
cortex [54].  Functionally, the insular regions are connected with the anterior cingulate cortex and the 
frontal lobe, particularly, the inferior frontal gyrus [55], and all these areas are functionally connected 
in healthy participants.  Dysfunction in this brain network may contribute to the presence of apathy in 
PD as there seems to be both functional and structural grounds for this explanation.  It has been 
suggested that the insula plays a role in subjective emotional experience; atrophy in this area may 
reflect loss of emotional responsiveness or spontaneous emotion, which is considered as one of the 
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most prominent features of apathy [56].  In older people with only apathy (without PD), higher apathy 
scores were associated with grey matter reduction in the right anterior cingulate gyrus [57].  This 
brain area has a major functional impact in terms of the initiation and motivational drivers for goal 
directed behaviours and activities, and atrophy in this region, therefore, may lead to behavioural and 
cognitive changes with a consequent loss of goal directed actions [58].  A recent resting-state fMRI 
study [59] reported that apathetic PD patients showed functional connectivity reductions in the 
frontal, limbic and striatum areas when compared with non-apathetic PD patients or healthy controls 
[59].  These findings are in line with the present results, particularly the involvement of the frontal 
cortex and the limbic system, and together would provide an explanation for the presence of apathy in 
PD from a structural and functional perspective.    
Levy and Dubois [30] suggested that apathy may occur as a consequence of disturbance in the 
prefrontal-basal ganglia system, and distinguished three subtypes of processing disturbance which are 
emotional-affective, cognitive, and auto-activation. Specifically, the auto-activation deficit has been 
associated with frontal white matter lesions [30]. In addition, the involvement of the cingulate gyrus 
and premotor cortex, as found in the present study, lends support to the hypothesis that deficits of 
auto-activation processing could be responsible for apathy in PD.  The behavioural results lend 
support to the present imaging findings of greater structural atrophy particularly in the frontal lobe, 
temporal lobe and the anterior cingulate cortex in patients with apathy. 
In this study, we identified some structural brain regions that might underlie the occurrence of 
apathy symptom in patients who have PD. In patients with apathy, significant grey and white matter 
loss was found mainly in the frontal lobe areas and the insula region. An fMRI study reported that the 
orbital frontoinsular regions are connected with other brain areas including subcortical structures [60]. 
The basal ganglia, part of a subcortical network of structures, when dysfunctional may be crucially 
involved in the genesis of apathy in patients with PD [61]. In particular, dysfunction of the 
dopaminergic system may be crucial because it plays an integrative and regulatory role in the 
development and interpretation of emotions, motor control and reward processes [61, 62]. These data 
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suggest that perturbation of homeostasis of the brain network which includes the frontal lobe, insula 
and the basal ganglia might be an important factor contributing to the appearance of apathy in PD. 
Grey matter loss in the inferior parietal gyrus was also observed in apathetic patients with PD 
[17]. This structural loss has also been linked to executive dysfunction in PD [63]. It has been 
suggested that the parietal lobe plays a crucial role in incorporating information from different senses 
and processes [17].  Kjaer et al [64] hypothesised that the inferior parietal gyrus, the precuneus and 
the anterior cingulate gyrus constitute a functional network of reflective self-awareness.  These 
findings therefore imply that executive dysfunction in patients with PD with apathy may reflect 
damage not only in the frontal lobe, but also in the parietal lobe with the consequent disruption of 
associated functions and cognitive processing.   
Interestingly, the present study also identified grey matter loss in the left cerebellum. This 
result supports the findings of a recent PET study, which demonstrated negative correlations between 
apathy and metabolism in the cerebellum bilaterally in patients with PD [31].  There is some evidence 
indicating the role of the cerebellum in cognition and emotion with some clinical case reports having 
demonstrated that cerebellar lesions are responsible for a range of behavioural abnormalities (such as 
apathy), emotional dysregulation and executive dysfunction [65], all relevant for apathy.  These 
observations are supported by the existence of structural connections between the cerebellum and the 
prefrontal cortex via the thalamus [66].  The current findings seem to support this view, suggesting 
that an overall disruption of a cerebellum/frontal network of structures may be a relevant prerequisite 
for the presence of apathy and executive dysfunction in PD. Apathy in this sample was measured not 
with a symptom specific scale, but with a multi-symptom neuropsychiatric inventory such as the NPI.  
Although this might be seen as a limitation of this study, it also represents a strength since the use of 
the NPI allowed the selection of a sample free from contamination of other possible neuropsychiatric 
comorbidities, which would have lowered the reliability of the findings. 
In conclusion, the present finding on apathy provides evidence of a specific association 
between aspects of cognitive decline, and regional brain atrophy in patients with PD and apathy.  The 
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neuropsychological findings emphasise that patients with apathy have cognitive impairment, 
particularly, executive dysfunction and memory deficits.  In addition, the imaging results identified 
loss of volume in brain regions, which are normally associated with cognitive abilities on which 
patients with apathy performed more poorly.  
The current findings have several implications for patients with PD, their families and 
clinicians. For example, increasing awareness of the potential presence of apathy while the symptom 
is still mild may help treatment of this symptom, before it begins to have an even greater negative 
impact on the cognitive abilities of patients. Apathy appears to be associated with cognitive 
impairments in PD, therefore, treatment of this symptom might mitigate its effects on cognitive 
performance in this clinical population.    
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Table 1 Mean (SD, range) Age, Education, Duration of disease and MMSE of all patients with PD, 
patients with PD with apathy, patients with PD without neuropsychiatric symptoms (NPSS), and 
controls 
 
All PD  
(N =65) 
PD with apathy 
(N = 25) 
PD without 
NPSS 
(N =40) 
Controls 
(N = 24) 
P 
Age 67.73 (8.06, 48-80) 68.7 (8.4, 49-80) 66.1 (8.5, 48-80) 62.79 (9.77, 50-81) .108 
Education 11.1 (4.56, 5-18) 10.9 (4.5, 5-18) 11.2 (4.7, 5-18) 12.21 (5.49, 5-24) .678 
Duration 
of disease 
8.98 (5.27) 10.3 (5.98) 7.9 (4.5) --- .162 
MMSE 27.9 (1.7, 24-30) 27.22 (1.8, 24-30) 28.2 (1.4, 26-30) 30.00 (.000) .000* 
*Significant difference between controls and the two groups of patients (with and without apathy) using 
Bonferroni Post-hoc test 
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Table 2 Mean (SD), and P value of scores on neuropsychological tests achieved by PD with apathy 
and PD without neuropsychiatric symptoms (NPSS). 
 PD with apathy 
(N = 25) 
PD without NPSS 
 (N = 40) 
p 
Raven’s Progressive Matrices 20.44 (13.57) 28.7 (9.35) .005 
Stroop test    
  Time interference effect 33.43 (18.82) 37.16 (35.49) .671 
  Error interference effect 3.88 (5.68) .93 (1.37) .002* 
Trail Making Test 31.28 (46.67) 51.08 (52.68) .129 
Letter Fluency Test 26.32 (8.88) 36.15 (13.78) .002* 
Category Fluency Test 29.36 (11.03) 36.73 (10.87) .010 
Similarities Test 13.84 (6.27) 15.80 (5.99) .212 
Rey Complex Figure    
  Direct copy 23.50 (9.79) 29.56 (6.92) .005 
  Delayed copy 10.78 (5.40) 13.49 (6.06) .086 
Digit Span    
  Forward 5.86 (1.29) 6.15 (1.01) .426 
  Backward 3.79 (.69) 4.12 (1.11) .320 
Frontal Assessment Battery 13.77 (2.56) 15.69 (1.93) .012 
Visual-spatial span 4.36 (1.08) 4.72 (1.06) .316 
Rey 15-word Memory Test 6.33 (2.98) 9.02 (2.03) .029 
*Significant difference between PD with apathy and PD without neuropsychiatric symptoms P < 0.004 
(corrected for multiple comparison)  
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Table 3 Areas of significant grey matter volume value differences between the two PD patients and 
controls 
Brain areas R/L BA Cluster 
Size 
Cluster-level 
P-value 
(corrected)  
Z value at 
Local 
Maximum 
Talairach 
coordinates 
   X         Y         Z 
PD with apathy vs PD without NPSS          
     Inferior frontal gyrus L 46 164 0.022 3.67 -44 39 9 
     Middle frontal gyrus L 10   3.44 -48 34 15 
     Precentral gyrus L 6   3.42 -44 21 34 
     Cingulate gyrus L 32 177 0.019 3.64 0 34 26 
     Anterior cingulate R 32   3.37 4 41 13 
  R 32   2.79 2 44 -6 
     Superior temporal gyrus L 41 161 0.023 3.42 -48 -32 13 
     Sub-lobar (Insula) L    3.26 -40 -12 -1 
  L    2.86 -42 -19 3 
PD with apathy vs controls         
     Inferior frontal gyrus R 45 834 0.000 5.35 50 37 7 
     Middle frontal gyrus R 10   4.77 40 51 7 
  R 9   4.74 44 34 26 
     Inferior parietal lobule R 40 100 0.001 5.09 44 -39 44 
     Middle frontal gyrus L 9 719 0.000 4.81 -44 31 28 
  L 10   4.68 -42 43 14 
     Inferior frontal gyrus L 9   4.66 -51 7 25 
     Parahippocampal gyrus L 34 67 0.021 4.59 -16 1 -12 
     Cerebellum (Anterior lobe)  L  295 0.001 4.37 -34 -40 -23 
                         (Posterior lobe)  L    4.14 -44 -52 -23 
     Fusiform gyrus L 19   4.08 -24 -61 -7 
     Cingulate gyrus L 24 69 0.032 4.03 -2 -2 42 
PD without NPSS vs controls         
     Inferior frontal gyrus L 9 56 0.001 5.28 -51 5 26 
     Middle frontal gyrus L 10 71 0.002 4.63 -36 45 5 
  R = Right    L = Left    BA = Brodmann Area 
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Table 4 Areas of significant white matter volume value differences between patients and controls 
Brain areas R/L Cluster 
Size 
Cluster-level 
P-value 
(corrected) 
Z value at 
Local 
Maximum   
Talairach 
coordinates 
  X          Y           Z 
PD with apathy vs controls        
     Middle frontal gyrus R  2655 0.000 5.28 28 4 37 
     Sub-lobar (Insula) R   4.55 28 26 12 
     Anterior cingulate gyrus R   4.44 20 41 5 
   L 2669 0.000 4.95 -14 17 30 
     Precentral gyrus L   4.51 -32 1 22 
     Middle frontal gyrus  L    4.48 -26 23 23 
PD without NPSS vs controls        
     Medial frontal gyrus R  396 0.002 4.34 20 47 9 
     Frontal lobe (sub-gyral) R   3.37 26 28 12 
  R   3.32 18 33 -7 
     Precentral gyrus  L 143 0.010 4.19 -32 -15 43 
     Middle frontal gyrus L     3.54 -28 21 28 
R = Right    L = Left     
  
27 
Figure captions 
 
Figure 1 Areas of significantly less grey matter volume values in patients groups and healthy controls   
 
Figure 2 Areas of significantly less white matter volume values in patients with PD when compared with 
healthy controls 
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